Di Carlo F - Search Results

1

Correlations among receptor status, estrogen receptor (ER) form (8S and/or 4S) and labelling index (LI) in human breast cancer.

Badino P, Conti G, Giubertoni M, Racca S, Di Carlo F. Badino P, et al. Among authors: di carlo f. Pharmacol Res. 1990 Sep-Oct;22 Suppl 3:5-6. doi: 10.1016/1043-6618(90)90558-u. Pharmacol Res. 1990. PMID: 2097642 No abstract available.

2

Interference of gestagens and androgens with rat uterine oestrogen receptors.

Di Carlo F, Conti G, Reboani C. Di Carlo F, et al. J Endocrinol. 1978 Apr;77(1):49-55. doi: 10.1677/joe.0.0770049. J Endocrinol. 1978. PMID: 147913

3

Changes in the concentration of uterine cytoplasmic oestrogen receptors induced by doxorubicin and methotrexate.

Di Carlo F, Reboani C, Conti G, Genazzani E. Di Carlo F, et al. J Endocrinol. 1978 Nov;79(2):201-8. doi: 10.1677/joe.0.0790201. J Endocrinol. 1978. PMID: 731145

4

[Mechanism of action of progestins in the treatment of hormone-dependent breast cancer (author's transl)].

Di Carlo F, Pacilio G, Conti G. Di Carlo F, et al. Tumori. 1975 Nov-Dec;61(6):501-8. doi: 10.1177/030089167506100601. Tumori. 1975. PMID: 1224393 Italian.

5

Effects of a beta 2-agonist (clenbuterol) on cultured human (CG-5) breast cancer cells.

Re G, Badino P, Girardi C, Di Carlo F. Re G, et al. Among authors: di carlo f. Pharmacol Res. 1992 Dec;26(4):377-84. doi: 10.1016/1043-6618(92)90236-5. Pharmacol Res. 1992. PMID: 1294941

6

Opposite effects of dehydroepiandrosterone on the growth of 7,12-dimethylbenz(a)anthracene-induced rat mammary carcinomas.

Boccuzzi G, Aragno M, Brignardello E, Tamagno E, Conti G, Di Monaco M, Racca S, Danni O, Di Carlo F. Boccuzzi G, et al. Among authors: di monaco m, di carlo f. Anticancer Res. 1992 Sep-Oct;12(5):1479-83. Anticancer Res. 1992. PMID: 1444210

7

Potentiation of medroxyprogesterone acetate antineoplastic activity by histidine in rat mammary tumours.

Di Carlo F, Conti G, Giubertoni M, Muccioli G, Racca S. Di Carlo F, et al. Cancer Chemother Pharmacol. 1991;27(4):271-7. doi: 10.1007/BF00685111. Cancer Chemother Pharmacol. 1991. PMID: 1825621

8

Histidine increases estrogen and progesterone receptor levels in rat mammary tumors.

Racca S, Badino P, Carozzi S, Conti G, Giubertoni M, Squillario P, Di Carlo F. Racca S, et al. Among authors: di carlo f. Pharmacol Res. 1990 Sep-Oct;22 Suppl 3:13-4. doi: 10.1016/s1043-6618(09)80006-6. Pharmacol Res. 1990. PMID: 2129062 No abstract available.

9

Histidine potentiates the antiproliferative effect of medroxyprogesterone acetate (MPA) on a human breast cancer cell line.

Giubertoni M, Badino P, Conti G, Racca S, Di Carlo F. Giubertoni M, et al. Among authors: di carlo f. Pharmacol Res. 1990 Sep-Oct;22 Suppl 3:9-10. doi: 10.1016/s1043-6618(09)80004-2. Pharmacol Res. 1990. PMID: 2151472 No abstract available.

10

Medroxyprogesterone acetate (MPA) stimulates adenylate cyclase activity in rat mammary tumours.

Racca S, Conti G, Muccioli G, Paradisi L, Giubertoni M, Badino P, Di Carlo F. Racca S, et al. Among authors: di carlo f. Pharmacol Res. 1989 Nov-Dec;21 Suppl 1:81-2. doi: 10.1016/s1043-6618(89)80062-3. Pharmacol Res. 1989. PMID: 2517342 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

268 results

Search Page

Filters